255 related articles for article (PubMed ID: 19416168)
1. Addition of a carboxy-terminal green fluorescent protein does not alter the binding and signaling properties of relaxin family Peptide receptor 3.
van der Westhuizen ET; Wade JD; Sexton PM; Summers RJ
Ann N Y Acad Sci; 2009 Apr; 1160():105-7. PubMed ID: 19416168
[TBL] [Abstract][Full Text] [Related]
2. The relaxin family peptide receptor 3 activates extracellular signal-regulated kinase 1/2 through a protein kinase C-dependent mechanism.
van der Westhuizen ET; Werry TD; Sexton PM; Summers RJ
Mol Pharmacol; 2007 Jun; 71(6):1618-29. PubMed ID: 17351017
[TBL] [Abstract][Full Text] [Related]
3. H2 relaxin is a biased ligand relative to H3 relaxin at the relaxin family peptide receptor 3 (RXFP3).
van der Westhuizen ET; Christopoulos A; Sexton PM; Wade JD; Summers RJ
Mol Pharmacol; 2010 May; 77(5):759-72. PubMed ID: 20159943
[TBL] [Abstract][Full Text] [Related]
4. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135).
Zhu J; Kuei C; Sutton S; Kamme F; Yu J; Bonaventure P; Atack J; Lovenberg TW; Liu C
Eur J Pharmacol; 2008 Aug; 590(1-3):43-52. PubMed ID: 18582868
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and characterization of a single-chain peptide antagonist for the relaxin-3 receptor RXFP3.
Haugaard-Kedström LM; Shabanpoor F; Hossain MA; Clark RJ; Ryan PJ; Craik DJ; Gundlach AL; Wade JD; Bathgate RA; Rosengren KJ
J Am Chem Soc; 2011 Apr; 133(13):4965-74. PubMed ID: 21384867
[TBL] [Abstract][Full Text] [Related]
6. Roles of the receptor, the ligand, and the cell in the signal transduction pathways utilized by the relaxin family peptide receptors 1-3.
Summers RJ; Bathgate RA; Wade JD; van der Westhuizen ET; Halls ML
Ann N Y Acad Sci; 2009 Apr; 1160():99-104. PubMed ID: 19416167
[TBL] [Abstract][Full Text] [Related]
7. Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1.
Shabanpoor F; Akhter Hossain M; Ryan PJ; Belgi A; Layfield S; Kocan M; Zhang S; Samuel CS; Gundlach AL; Bathgate RA; Separovic F; Wade JD
J Med Chem; 2012 Feb; 55(4):1671-81. PubMed ID: 22257012
[TBL] [Abstract][Full Text] [Related]
8. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
[TBL] [Abstract][Full Text] [Related]
9. Quantitative measurement of cell membrane receptor internalization by the nanoluciferase reporter: Using the G protein-coupled receptor RXFP3 as a model.
Liu Y; Song G; Shao XX; Liu YL; Guo ZY
Biochim Biophys Acta; 2015 Feb; 1848(2):688-94. PubMed ID: 25434927
[TBL] [Abstract][Full Text] [Related]
10. The structural and functional role of the B-chain C-terminal arginine in the relaxin-3 peptide antagonist, R3(BDelta23-27)R/I5.
Hossain MA; Bathgate RA; Rosengren KJ; Shabanpoor F; Zhang S; Lin F; Tregear GW; Wade JD
Chem Biol Drug Des; 2009 Jan; 73(1):46-52. PubMed ID: 19152634
[TBL] [Abstract][Full Text] [Related]
11. Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms.
Halls ML; Bathgate RA; Summers RJ
Mol Pharmacol; 2006 Jul; 70(1):214-26. PubMed ID: 16569707
[TBL] [Abstract][Full Text] [Related]
12. The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation.
Wang XY; Guo YQ; Zhang WJ; Shao XX; Liu YL; Xu ZG; Guo ZY
FEBS J; 2014 Jul; 281(13):2927-36. PubMed ID: 24802387
[TBL] [Abstract][Full Text] [Related]
13. Activation of relaxin-related receptors by short, linear peptides derived from a collagen-containing precursor.
Shemesh R; Hermesh C; Toporik A; Levine Z; Novik A; Wool A; Kliger Y; Rosenberg A; Bathgate RA; Cohen Y
Ann N Y Acad Sci; 2009 Apr; 1160():78-86. PubMed ID: 19416163
[TBL] [Abstract][Full Text] [Related]
14. Receptor-coupling properties of the invertebrate visual guanine nucleotide binding protein iGqalpha.
Go L; Mitchell J
Cell Signal; 2007 Sep; 19(9):1919-27. PubMed ID: 17560078
[TBL] [Abstract][Full Text] [Related]
15. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.
Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ
Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890
[TBL] [Abstract][Full Text] [Related]
16. Relaxin-3, INSL5, and their receptors.
Liu C; Lovenberg TW
Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
[TBL] [Abstract][Full Text] [Related]
17. Structure and activity in the relaxin family of peptides.
Tregear GW; Bathgate RA; Hossain MA; Lin F; Zhang S; Shabanpoor F; Scott DJ; Ma S; Gundlach AL; Samuel CS; Wade JD
Ann N Y Acad Sci; 2009 Apr; 1160():5-10. PubMed ID: 19416150
[TBL] [Abstract][Full Text] [Related]
18. Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous system.
Sutton SW; Shelton J; Smith C; Williams J; Yun S; Motley T; Kuei C; Bonaventure P; Gundlach A; Liu C; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():242-9. PubMed ID: 19416196
[TBL] [Abstract][Full Text] [Related]
19. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides.
Bathgate RA; Ivell R; Sanborn BM; Sherwood OD; Summers RJ
Pharmacol Rev; 2006 Mar; 58(1):7-31. PubMed ID: 16507880
[TBL] [Abstract][Full Text] [Related]
20. Signalling profiles of H3 relaxin, H2 relaxin and R3(BΔ23-27)R/I5 acting at the relaxin family peptide receptor 3 (RXFP3).
Kocan M; Sarwar M; Hossain MA; Wade JD; Summers RJ
Br J Pharmacol; 2014 Jun; 171(11):2827-41. PubMed ID: 24641548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
